Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy

Benzer Materyaller

• CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
  Yazar:: Miri, Seyed Mohammad, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
  Yazar:: Seyed Mohammad Miri, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-10-01)
• CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy
  Yazar:: Salas-Mckee, January, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Gene editing (CRISPR-Cas) technology and fisheries sector
  Yazar:: A.D. Diwan, ve diğerleri
  Baskı/Yayın Bilgisi: (2017-07-01)
• CRISPR-Cas systems: ushering in the new genome editing era
  Yazar:: Perez Rojo, Fernando, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)